Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 214.50
Bid: 214.00
Ask: 215.50
Change: -2.50 (-1.15%)
Spread: 1.50 (0.701%)
Open: 213.50
High: 215.50
Low: 212.50
Prev. Close: 217.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

3 Jun 2008 12:11

RNS Number : 8438V
Advanced Medical Solutions Grp PLC
03 June 2008
 



For immediate release 

June  2008

Advanced Medical Solutions Group plc 

("AMS" or "the Company")

Result of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, held its Annual General Meeting this morning at which all resolutions put to shareholders were duly passed. 

Don Evans, AMS's Chief Executive Officer, gave a presentation at the AGM, the slides from which will be made available at the Company's website, www.admedsol.com.

For further information, please contact:

Advanced Medical Solutions Group plc

Don Evans, Chief Executive Officer

Mary Tavener, Finance Director

www.admedsol.com

  

Tel: +44 (0) 1606 545508

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Mark Court, Mary-Jane Johnson

Landsbanki Securities (UK) Ltd

Shaun DobsonClaes Spang

Tel: +44 (0) 20 7426 9000

Notes to Editors:

Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSSWFFDSASESM
Date   Source Headline
29th Jan 20214:36 pmRNSTotal Voting Rights
22nd Jan 202111:31 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSDirectorate Change
12th Jan 20217:00 amRNSTrading Update
8th Jan 20215:37 pmRNSHolding(s) in Company
31st Dec 202010:00 amRNSTotal Voting Rights
15th Dec 20209:47 amRNSHolding(s) in Company
30th Nov 20201:29 pmRNSTotal Voting Rights
23rd Nov 20207:00 amRNSAMS Acquisition of Raleigh Coatings
20th Nov 20207:00 amRNSCE mark approval for Silicone PHMB Foam Dressing
16th Nov 20201:29 pmRNSHoldings in Company
19th Oct 20203:29 pmRNSHolding(s) in Company
16th Sep 20207:00 amRNSInterim Results
15th Sep 20202:48 pmRNSBlock listing Interim Review
3rd Sep 20207:00 amRNSNotice of Results
14th Aug 202012:02 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSUK and US Patents Granted for LiquiBand® Exceed
31st Jul 20201:29 pmRNSTotal Voting Rights
9th Jul 20207:00 amRNSTrading Update
30th Jun 20205:52 pmRNSTotal Voting Rights
19th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 202012:02 pmRNSPrice Monitoring Extension
10th Jun 202011:30 amRNSResult of Annual General Meeting
10th Jun 20207:00 amRNSAGM Trading and US LiquiBand® Update
29th May 20202:17 pmRNSTotal Voting Rights
18th May 20207:00 amRNSAnnual Report, AGM and Board Change
12th May 20206:16 pmRNSDirector/PDMR Shareholding
11th May 20204:01 pmRNSDirector/PDMR Shareholding
30th Apr 20202:00 pmRNSTotal Voting Rights
17th Apr 20204:30 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSPCA Dealing
6th Apr 20209:26 amRNSDirector/PDMR and PCA Shareholding
6th Apr 20207:01 amRNSClinical Development Programme
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:06 amRNSHoldings in Company
13th Mar 20205:00 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSUnaudited Preliminary Results
10th Mar 20207:00 amRNSBlock listing Interim Review
10th Mar 20207:00 amRNSFDA Approval of LiquiBand® Rapid(TM)
11th Feb 202010:03 amRNSHolding(s) in Company
15th Jan 20207:00 amRNSYear End Trading Update
31st Dec 201912:18 pmRNSTotal Voting Rights
2nd Dec 20197:00 amRNSAcquisition of Biomatlante SA
29th Nov 20193:08 pmRNSTotal Voting Rights
29th Nov 20197:00 amRNSThird party sterilisation failure
31st Oct 20193:13 pmRNSTotal Voting Rights
31st Oct 20193:09 pmRNSHolding(s) in Company
16th Sep 201911:15 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.